BDI-1-MT治疗膀胱癌及预防其术后复发的临床观察

目的　通过临床应用膀胱腔内灌注抗人膀胱癌免疫毒素 (BDI- 1-MT) ,观察治疗膀胱癌和预防膀胱癌术后复发的效果及毒副反应。方法　对 18例术后和 5例未手术的膀胱癌病人 ,膀胱腔内灌注BDI- 1-MT 1个疗程以上 ,观察疗效、复发情况及毒副反应。结果　术后 18例随访 6～ 2 0个月未见复发 ,未手术 5例随访 6～ 2 1个月 ,其中 3例显效 ,2例有效。所有病例均无明显毒副反应。结论　膀胱腔内灌注BDI- 1-MT治疗膀胱癌和预防膀胱癌术后复发有良好效果 ,是一种值得推广的新方法。     

凝集素受体在膀胱癌中的分布

目的：探讨膀胱癌中凝集素受体分布与其分化程度和浸润深度的关系。方法：应用生物素标记的花生凝集素（ＰＮＡ）、麦胚凝集素（ＷＧＡ）及刀豆凝集素（ＣｏｎＡ）等３种凝集素对５２例人体膀胱癌、１０例正常人体膀胱粘膜，进行亲合组织化学法研究。结果：发现正常膀胱粘膜ＰＮＡ、ＷＧＡ受体阴性，ＰＮＡ受体阳性率随膀胱癌病理分级的上升而递增，差异具有显著性意义（Ｐ＜０．０５）。ＰＮＡ、ＷＧＡ受体阳性率在浸润性肿瘤中明显高于浅表性肿瘤（Ｐ＜０．０５）。结论：提示ＰＮＡ、ＷＧＡ受体阳性率与膀胱癌分化程度和浸润深度有关。     

原发性膀胱腺癌临床病理分析

对６例原发性膀胱腺癌进行临床病理分析，患者年龄４０～７６岁，男４例，女２例。术前病程多为２个月，以血尿症状为主。６例均经病理检查证实，其中４例加做ＰＡＳ染色，证实有ＰＡＳ阳性物质，免疫组化标记ＣＥＡ４例，有３例呈阳性结果。本组随访结果５例死亡，存活时间９～４３月，１例尚存活１３月。结合文献着重讨论了影响膀胱腺癌预后诸因素。     

可控盲结肠膀胱术19例

目的 :探讨膀胱全切术后可控盲结肠膀胱术的选择及应用。方法 :回顾性分析我科 1 9例可控盲结肠膀胱术患者的临床资料。结果 :1 9例患者术后恢复较好 ,储尿囊平均容量 4 80ml,平均压力 (1 .96± 0 .4 9)kPa ,排尿控制较好 ,插管容易 ,无尿失禁及输尿管反流。结论 :可控盲结肠膀胱术具高容量、低内压、控制排尿等特点 ,可极大提高患者的生活质量 ,其中以可控去带盲结肠膀胱术最为简单、有效 ,值得临床应用     

醋酸棉酚诱导膀胱癌T24细胞凋亡的研究

目的　研究棉酚对膀胱癌T2 4 细胞的抑制作用和诱导凋亡作用 ,探讨其作用机制。方法　将不同浓度的醋酸棉酚作用于人T2 4 膀胱癌细胞 ,利用MTT法检测其有效作用浓度、瑞氏染色、流式细胞仪 ,观察T2 4 细胞的凋亡情况。结果　MTT法测得其IC50 值为 12 6.3 μmol·L-1,浓度为 5 0～ 3 0 0 μmol·L-1的棉酚具有诱导T2 4 细胞凋亡的作用 ,随着药物作用时间的延长凋亡率增加。结论　棉酚抗癌作用机制之一是诱导人T2 4 膀胱癌细胞凋亡     

Dermatomyositis in a patient with high grade papillary urothelial carcinoma of urinary bladder

Inflammatory myopathies like dermatomyositis are associated with increased incidence of malignancies. This association has been commonly reported with malignancies of ovaries, gastro‐intestinal tract, breast and non‐Hodgkin's lymphomas but occurrence of dermatomyositis with bladder cancer has been rarely reported. We report a patient with carcinoma bladder who developed dermatomyositis while being treated for the bladder cancer.     

膀胱癌组织P-gp,GST-π和TOPO-Ⅱ表达评估灌注化疗

目的：探讨膀胱癌的多药耐药性(MDR)，指导灌注化疗用药。方法：采用免疫组化法检测44例膀胱癌病理标本中P-糖蛋白(P-gp)、谷胱肽S转移酶(GST-π)和拓扑异构酶(TOPO—Ⅱ)的表达，评估肿瘤耐药谱。结果：①P-gp检测显示，54．5％的病例对阿毒索、丝裂毒索、长春新碱等抗生索类和生物碱类抗癌药高耐药。②GST-π检测显示仅34．1％的病例对顺铂、环磷酰胺等高耐药，而反有56．8％的病例对该类药无耐药或低度耐药。③TOPO-Ⅱ检测显示对阿霉索、柔红毒索、VP16等TOPO-Ⅱ抑制剂类抗癌药，仅13．6％的病例高度耐药，29．5％中度耐药。56．8％低度耐药。结论：检测膀胱癌MDR，了解多药耐药谱，可指导灌注化疗用药。     

飞行员配穿两种囊式抗荷服在不同环境温度和代谢水平时的热应激

目的　探讨飞行员配穿囊式抗荷服在不同环境温度、不同代谢水平条件下的热应激 ,为评价囊式抗荷服的热负荷和制定相应的保障措施提供理论依据。方法　 6名受试者分别配穿KH - 3抗荷服及配套装备和KH - 7抗荷服及配套装备 (以下分别简称为“KH - 3”和“KH -7”) ,以不同代谢水平暴露于 2 0℃、2 5℃和 35℃环境。每次试验 70min。测量了受试者配穿KH- 3和KH - 7时的卫生学参数、皮肤温度、直肠温度、心率等 ,并以综合热应激指数 (CIHS)评定了热应激防护等级。结果　KH - 3和KH - 7的各项卫生学参数 (clo值、im、im/IJ)均无显著差别。KH - 3对照Ⅲ组和KH - 7对照Ⅳ组 (2 5℃ ,1178～ 132 5kJ·h- 115min ,36 8kJ·h- 15 5min)的CIHS均未超过生理安全限的 6 0 % (分别为 3.5 4和 3.4 6 ,属轻度热应激 ) ;KH - 3高代谢组和KH- 7高代谢组 (2 0℃ ,84 6～ 10 30kJ·h- 170min)的CIHS在生理安全限的 6 0 %～ 95 %之间 (分别为4 .2 4和 4 .6 0 ,属中度热应激 ) ;KH - 3高温组和KH - 7高温组 (35℃ ,1178～ 132 5kJ·h- 115min ,36 8kJ·h- 15 5min)的CIHS却超过生理安全限的 95 % (分别为 7.31和 7.87,属重度热应激 )。结论　受试者配穿KH - 3与KH - 7时的各项卫生学参数、热应激等均无显著差别 ,但配穿后者比     

辣椒素对慢性脊髓损伤大鼠排尿功能的影响

目的：明确辣椒素对正常大鼠和慢性脊髓损伤(SCI)大鼠排尿功能的影响和作用的可能机制。方法：建立SCI的动物模型，实验大鼠和正常大鼠分别全身给药或膀胱内灌注辣椒素，记录膀胱内压力变化图(CMG)和尿道外括约肌肌电图(EUS-EMG)的改变。结果：正常大鼠辣椒素全身用药后出现非排尿性膀胱收缩，排尿效率下降，但排尿压不受影响。膀胱内灌注辣椒素亦会导致排尿效率降低而不影响排尿压。SCI大鼠全身用药后非排尿性膀胱收缩消失，残余尿量减少，排尿压下降，但排尿效率提高，膀胱内用药则可完全阻断排尿反射。结论：对辣椒素敏感的膀胱感觉传入神经参与正常大鼠和SCI大鼠的排尿反射。对正常大鼠起稳定膀胱逼尿肌的作用，而对SCI大鼠则是引起膀胱灌注时非排尿性收缩的原因，因此，阻滞感觉传入神经纤维是治疗SCI后膀胱高反射的有效方法。     

Prejunctional effects of muscarinic agonists on 3H-acetylcholine release in the rat urinary bladder strip

Summary The inhibitory effects of some muscarinic agonists on tritiated acetylcholine release evoked by field stimulation were investigated in the rat urinary bladder strip. The acetylcholine stores of the preparation were labelled with ³H-choline. Electrical field stimulation caused an outflow of tritium, reflecting the release of ³H-acetylcholine. The release of ³H-acetylcholine was decreased in a concentration-dependent manner by all the agonists tested: oxotremorine, muscarone, muscarine, carbachol and methylfurtrethonium. On the contrary, only muscarine and muscarone enhanced the basal efflux of tritium in a concentration-dependent fashion. Concentration-response curves were determined both at 2 Hz and at 1 Hz by using intermittent administration of the drugs. Maximal depression in release (by 78 – 82%) was observed in experiments at 1 Hz. A similar inhibition was obtained at 2 Hz frequency only when a low concentration of calcium (0.6 mM) in the medium was used. Oxotremorine was the most potent among the tested compounds with the same intrinsic activity as the other drugs. In contrast to the other agonists investigated, oxotremorine showed in about 10-fold greater potency at pre- than at postjunctional muscarine receptors in the rat urinary bladder. This difference might depend either on heterogeneity of muscarine receptors or on different mechanism(s) relating to the transducing properties of receptors at the pre- and postjunctional level. A comparison between the relative prejunctional potencies in the rat urinary bladder and in the guinea pig myenteric plexus (data from the literature) suggests that prejunctional muscarine receptors are similar in these tissues. Furthermore, the findings obtained with a low concentration of calcium in the medium may support the view that intraneuronal availability of calcium plays a significant role in modulating the prejunctional negative feed-back mechanism in the rat urinary bladder.Send offprint requests to Dr. G. D'Agostino at the above address